Untitled - The Canadian Association of Gastroenterology

744 PRINCIPES FONDAMENTAUX DE GASTRO-ENTÉROLOGIE
Section 11 Hépatopathie héréditaire
Asberg A, Hveem K, Thorstensen K, Ellekjter E, et al. Screening for haemochromatosis:
high prevalence and low morbidity in an unselected population of 65,238 persons.
Scand J Gastroenterol 2001; 36:1108-1115.
Beaton M, Guyader D, Deugnier Y, Moirand R, Chakrabarti S, Adams PC. Noninvasive
prediction of cirrhosis in C282Y-linked hemochromatosis. Hepatology 2002; 36:673-678.
Beutler E, Felitti V, Koziol J, Ho N, Gelbart T. Penetrance of the 845G to A (C282Y) HFE
hereditary haemochromatosis mutation in the USA. Lancet 2002; 359:211-218.
Feder JN, Gnirke A, Thomas W, et al. A novel MHC class I-like gene is mutated in
patients with hereditary haemochromatosis. Nat Genet 1996; 13:399-408.
Gitlin JD. Wilson disease. Gastroenterology 2003; 125:1868-1877.
Lomas DA, Mahadeva R. Alpha1-antitrypsin polymerization and the serpinopathies:
pathobiology and prospects for therapy. J Clin Invest 2002; 110:1585-1590.
Wojcik J, Speechley MR, Kertesz AE, Chakrabarti S, Adams PC. Natural history of
C282Y homozygotes for hemochromatosis. Can J Gastroenterol 2002; 16:297-302.
Section 12 Cholestase
Poupon R, Chazouilleres O, Poupon RE. Chronic cholestatic disease. J Hepatol 2000;
32(Suppl. 1):129-140.
Section 13 Cirrhose hépatique
Abraldes JG, Dell-Era A, Bosch J. Medical management of variceal bleeding in
patients with cirrhosis. Can J Gastroenterol 2004; 18:109-113.
Moore KP, Wong F, Gines P, et al. The management of ascites in cirrhosis: report on the
consensus conference of the Intenational Ascites Club. Hepatology 2003; 38:258-266.
Stewart SF, Day CP. The management of alcoholic liver disease. J Hepatol 2003; 38
(Suppl. 1):2-13.
Section 14 Hypertension portale
Bosch J, Abraldes JG. Management of gastrointestinal bleeding in patients with cirrhosis
of the liver. Semin Hematol 2004; 41(Suppl. 1):8-12.
Burak KW, Lee SS, Beck PL. Portal hypertensive gastropathy and gastric antral
vascular ectasia (GAVE) syndrome. Gut 2001; 49:866-872.
Comar KM, Sanyal AJ. Portal hypertensive bleeding. Gastroenterol Clin North Am
2003; 32:1079-1105.
D’Amico G. The role of vasoactive drugs in the treatment of oesophageal varices.
Expert Opin Pharmacother 2004; 5:349-360.
Ferguson JW, Tripathi D, Hayes PC. Review article: the management of acute variceal
bleeding. Aliment Pharmacol Ther 2003; 18:253-262.
Hoeper MM, Krowka MJ, Srassburg CP. Portopulmonary hypertension and hepatopulmonary
syndrome. Lancet 2004; 363:1461-1468.
Krowka MJ. Hepatopulmonary syndromes. Gut 2000; 46:1-4.
Liu H, Lee SS. Cardiopulmonary dysfunction in cirrhosis. J Gastroenterol Hepatol
1999; 14:600-608.
Liu H, Song D, Lee SS. Cirrhotic cardiomyopathy. Gastroenterol Clin Biol 2002; 26:
842-847.